Mouse RS21-C6 is a mammalian 2'-deoxycytidine 5'-triphosphate pyrophosphohydrolase that prefers 5-iodocytosine

Mari Nonaka1, Daisuke Tsuchimoto, Kunihiko Sakumi

  • 1Division of Neurofunctional Genomics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, Higashi-ku, Fukuoka, Japan.

The FEBS Journal
|February 18, 2009
PubMed

Insights

RS21-C6 protein hydrolyzes deoxynucleoside triphosphates, including modified forms like 5-iodo-dCTP, producing essential precursors for DNA synthesis and preventing potential DNA damage.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Nucleotides are crucial for cellular functions and can undergo modifications.
  • Modified nucleotides can be harmful and require elimination from cellular pools.
  • ITP, a modified nucleotide, signals potential cellular stress.

Purpose of the Study:

  • To identify proteins that bind to inosine triphosphate (ITP).
  • To characterize the enzymatic activity of the identified RS21-C6 protein.
  • To investigate the role of RS21-C6 in nucleotide metabolism and DNA integrity.

Main Methods:

  • Protein screening for ITP-binding activity.
  • Purification and characterization of recombinant RS21-C6 protein.
  • Enzymatic assays measuring pyrophosphohydrolase activity on various nucleotides.

Main Results:

  • RS21-C6 protein was identified and found to bind ITP and ATP.
  • Recombinant RS21-C6 exhibits pyrophosphohydrolase activity, preferring deoxynucleoside triphosphates and cytosine bases.
  • RS21-C6 efficiently hydrolyzes dCTP and 5-I-dCTP, with a higher affinity for the modified form.
  • The enzyme produces dCMP from dCTP, a precursor for dTTP synthesis.

Conclusions:

  • RS21-C6 generates dCMP from dCTP, supporting de novo dTTP synthesis.
  • RS21-C6 may protect cells from DNA damage by hydrolyzing modified dCTP, preventing mutagenesis and replication errors.

Related Concept Videos